Journal
TRENDS IN BIOTECHNOLOGY
Volume 22, Issue 8, Pages 423-427Publisher
ELSEVIER SCIENCE LONDON
DOI: 10.1016/j.tibtech.2004.06.008
Keywords
-
Categories
Funding
- NEI NIH HHS [EY 11832] Funding Source: Medline
- NIAID NIH HHS [1U01 AI 57233, AI 21694] Funding Source: Medline
Ask authors/readers for more resources
Smallpox was eradicated by the World Health Organization (WHO) vaccination campaign in the 1970s and the variola virus was restricted to repositories in the United States and Russia. Recently, however, concerns have arisen about the possible existence of variola outside these sites and the potential for using the virus as a weapon of bioterror. The world population now has little residual immunity to smallpox and supplies of the smallpox vaccine are being reconstituted. Large numbers of individuals with various skin diseases or immunosuppression owing to AIDS or organ transplantation medications, or who are pregnant or have heart disease might not be ideal candidates for vaccination with the current live vaccines. It would be useful to have an orally active drug that could be self-administered in case of an outbreak of smallpox.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available